SPOTLIGHT -
Dr. Waxman on the Future of Treatment in Multiple Myeloma
Adam J. Waxman, MD, MS, assistant professor of clinical medicine, Penn Medicine, University of Pennsylvania, discusses the future of treatment in patients with multiple myeloma.
Read More
Dr. Waxman on Selinexor in Multiple Myeloma Treatment
Adam J. Waxman, MD, MS, discusses the STORM trial and using selinexor to treat patients with multiple myeloma.
Dr. Waxman on the Role of Transplant in Multiple Myeloma
Adam J. Waxman, MD, MS, discusses the role of transplant in patients with multiple myeloma.
PD-1 Inhibitor Combinations, Alternative Therapeutic Approaches Are Moving the Needle in NSCLC
Better Understanding of Biomarkers Can Inform Immunotherapy Treatment in SCLC
Second-Line Treatment of R/R LBCL With Lisocabtagene Maraleucel (Liso-cel)
ZUMA-7: Axicabtagene Ciloleucel as a Second-Line Therapy for LBCL
